Sarepta Therapeutics, Inc. · NASDAQ:SRPT
Vanguard Capital Management LLC reported a 5.11% stake in Sarepta Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 30, 2026
Vanguard Capital Management LLC reported a 5.11% stake in Sarepta Therapeutics, Inc., 5,369,116 shares, as a passive investor on Mar 31, 2026. Filed Apr 30, 2026 (Schedule 13G).
- Stake
- 5.11%
- Shares
- 5,369,116
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.11% | 5,369,116 |
Source
Related
- Sarepta Therapeutics, Inc.
- Vanguard Capital Management LLC
- Sarepta Therapeutics, Inc. shareholders
- Form 4 · Wong Ryan Ho-Yan · Sep 8, 2026
- Form 4 · Estepan Ian Michael · Sep 8, 2026
- Form 4 · Rothfuss Cristin · Sep 8, 2026
- Form 4 · Rodino-Klapac Louise · Sep 8, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 13, 2026